| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy
|
Ogimoto, Akiyoshi
|
|
2005
|
149 |
3 |
p. e19-
1 p.
|
article
|
| 2 |
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
|
Armstrong, Paul W.
|
|
2005
|
149 |
3 |
p. 402-407
6 p.
|
article
|
| 3 |
Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS)
|
Ix, Joachim H.
|
|
2005
|
149 |
3 |
p. 512-519
8 p.
|
article
|
| 4 |
Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study
|
Macin, Stella M.
|
|
2005
|
149 |
3 |
p. 451-457
7 p.
|
article
|
| 5 |
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure
|
Frantz, Robert P.
|
|
2005
|
149 |
3 |
p. 541-547
7 p.
|
article
|
| 6 |
Change of address box
|
|
|
2005
|
149 |
3 |
p. 380-
1 p.
|
article
|
| 7 |
Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus
|
Reed, Shelby D.
|
|
2005
|
149 |
3 |
p. 434-443
10 p.
|
article
|
| 8 |
Coronary drug-eluting stent development: Issues in trial design
|
Muni, Neal I.
|
|
2005
|
149 |
3 |
p. 415-433
19 p.
|
article
|
| 9 |
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
|
Ballantyne, Christie M.
|
|
2005
|
149 |
3 |
p. 464-473
10 p.
|
article
|
| 10 |
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial
|
Smith, Charles S.
|
|
2005
|
149 |
3 |
p. 444-450
7 p.
|
article
|
| 11 |
Editorial Board
|
|
|
2005
|
149 |
3 |
p. A6-
1 p.
|
article
|
| 12 |
Electrocardiographic damage scores and cardiovascular mortality
|
Richardson, Kelly
|
|
2005
|
149 |
3 |
p. 458-463
6 p.
|
article
|
| 13 |
Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: Findings from the National Heart, Lung and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE)
|
Lewis, Jannet F.
|
|
2005
|
149 |
3 |
p. 527-533
7 p.
|
article
|
| 14 |
Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes
|
Kandzari, David E.
|
|
2005
|
149 |
3 |
p. 474-481
8 p.
|
article
|
| 15 |
Information for Authors
|
|
|
2005
|
149 |
3 |
p. A7-A8
nvt p.
|
article
|
| 16 |
Information for Readers
|
|
|
2005
|
149 |
3 |
p. A10-
1 p.
|
article
|
| 17 |
Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?
|
Al-Shaer, Moutasim H.
|
|
2005
|
149 |
3 |
p. e17-
1 p.
|
article
|
| 18 |
Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes
|
Zhang, Yan
|
|
2005
|
149 |
3 |
p. 497-503
7 p.
|
article
|
| 19 |
Letter to the editor
|
Nagge, Jeff
|
|
2005
|
149 |
3 |
p. e21-
1 p.
|
article
|
| 20 |
Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients
|
John, Stefan
|
|
2005
|
149 |
3 |
p. 473.e1-473.e10
4.729999995271E12 p.
|
article
|
| 21 |
Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression
|
Biondi-Zoccai, Giuseppe G.L.
|
|
2005
|
149 |
3 |
p. 504-511
8 p.
|
article
|
| 22 |
New-onset paroxysmal atrial fibrillation: Is permanence inevitable?
|
Patton, Kristen K.
|
|
2005
|
149 |
3 |
p. 388-390
3 p.
|
article
|
| 23 |
Patients with heart failure who die in hospice
|
Zambroski, Cheryl Hoyt
|
|
2005
|
149 |
3 |
p. 558-564
7 p.
|
article
|
| 24 |
Plaque regression—A new target for antiatherosclerotic therapy
|
Karha, Juhana
|
|
2005
|
149 |
3 |
p. 384-387
4 p.
|
article
|
| 25 |
Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting
|
Rajagopal, Vivek
|
|
2005
|
149 |
3 |
p. 534-540
7 p.
|
article
|
| 26 |
Prevalence of anemia and effects on mortality in patients with heart failure
|
Lindenfeld, JoAnn
|
|
2005
|
149 |
3 |
p. 391-401
11 p.
|
article
|
| 27 |
Primary stenting of occluded native coronary arteries II—Rationale and design of the PRISON II study: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions
|
Rahel, Braim M.
|
|
2005
|
149 |
3 |
p. 414.e1-414.e3
409861 p.
|
article
|
| 28 |
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation
|
Kerr, Charles R.
|
|
2005
|
149 |
3 |
p. 489-496
8 p.
|
article
|
| 29 |
Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease
|
Mix, T.-Christian H.
|
|
2005
|
149 |
3 |
p. 408-413
6 p.
|
article
|
| 30 |
Reducing the costs of phase III cardiovascular clinical trials
|
Eisenstein, Eric L.
|
|
2005
|
149 |
3 |
p. 482-488
7 p.
|
article
|
| 31 |
Reply
|
Kruse, Michael W.
|
|
2005
|
149 |
3 |
p. e23-e24
nvt p.
|
article
|
| 32 |
Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound
|
Petronio, Anna Sonia
|
|
2005
|
149 |
3 |
p. 520-526
7 p.
|
article
|
| 33 |
Statins in acute coronary syndromes: The sooner, the better?
|
Schwartz, Gregory G.
|
|
2005
|
149 |
3 |
p. 377-380
4 p.
|
article
|
| 34 |
Statin therapy—Time to turn the focus from efficacy to implementation?
|
Blazing, Michael
|
|
2005
|
149 |
3 |
p. 381-383
3 p.
|
article
|
| 35 |
TOC
|
|
|
2005
|
149 |
3 |
p. A2-A5
nvt p.
|
article
|
| 36 |
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
|
Maggioni, Aldo P.
|
|
2005
|
149 |
3 |
p. 548-557
10 p.
|
article
|
| 37 |
Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction
|
Steen, Henning
|
|
2005
|
149 |
3 |
p. 564.e1-564.e7
5.639994361E9 p.
|
article
|
Journal description